Literature DB >> 28875766

Postprandial glucose and healthcare resource use: a cross-sectional survey of adults with diabetes treated with basal-bolus insulin.

Kathryn M Pfeiffer1, Anna Sandberg2, Annie Nikolajsen2, Meryl Brod1.   

Abstract

AIMS: Postprandial glucose (PPG) control is a well-known challenge for diabetes management, yet there is limited research on how PPG affects healthcare resource utilization. This study investigated the association between PPG levels and healthcare resource utilization among adults with diabetes treated with basal-bolus insulin.
METHODS: A web-based, cross-sectional survey (n = 940) of adults with type 1 or type 2 diabetes and treated with basal and bolus insulins was conducted in Italy, the UK, and the US. Descriptive analyses included frequencies, cross-tabulations, and comparison of means. Incidence-rate ratios (IRR) were calculated using negative binomial regression analysis to investigate the relationship between elevated PPG and healthcare resource utilization. Models controlled for demographic characteristics, duration of diabetes, and diabetes-related complications.
RESULTS: Among respondents who measured PPG regularly and reported their two highest PPG values in the past week (n = 691), the mean average highest PPG value was 11.9 mmol/L (SD = 4.0). On average, holding other variables constant at their means, a 1 mmol/L increase in PPG was associated with an increase in healthcare resource utilization related to diabetes and elevated PPG, including the expected number of healthcare provider (HCP) visits in the past 6 months (IRR [95% CI] = 1.14 [1.08-1.21], p < .001), the expected number of calls/emails to HCPs in the past 6 months (IRR [95% CI] = 1.12 [1.06-1.19], p < .001), and the expected number of overnight hospitalizations in the past year (IRR [95% CI] = 1.14 [1.07-1.23], p < .001). LIMITATIONS: The study relied on self-reported data, which may be subject to recall bias. Given the cross-sectional nature of the study, results should be interpreted with caution.
CONCLUSIONS: Increased PPG levels were significantly associated with increased healthcare resource utilization among adults with diabetes. Additional education regarding PPG monitoring may help improve the day-to-day management of diabetes and reduce healthcare costs.

Entities:  

Keywords:  Diabetes mellitus, type 1; diabetes management; diabetes mellitus, type 2; healthcare resource utilization; postprandial glucose; postprandial hyperglycemia

Mesh:

Substances:

Year:  2017        PMID: 28875766     DOI: 10.1080/13696998.2017.1377208

Source DB:  PubMed          Journal:  J Med Econ        ISSN: 1369-6998            Impact factor:   2.448


  5 in total

1.  Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis.

Authors:  Hideaki Jinnouchi; Makoto Imori; Hiroshi Nishiyama; Takeshi Imaoka
Journal:  Diabetes Ther       Date:  2020-07-29       Impact factor: 2.945

2.  Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients with Type 1 Diabetes: PRONTO-T1D Subpopulation Analysis.

Authors:  Junnosuke Miura; Makoto Imori; Hiroshi Nishiyama; Takeshi Imaoka
Journal:  Diabetes Ther       Date:  2020-07-29       Impact factor: 2.945

3.  Ultra-Rapid Lispro Improves Postprandial Glucose Control and Time in Range in Type 1 Diabetes Compared to Lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy.

Authors:  Maciej T Malecki; Dachuang Cao; Rong Liu; Thomas Hardy; Bruce Bode; Richard M Bergenstal; Juliana Bue-Valleskey
Journal:  Diabetes Technol Ther       Date:  2020-06-10       Impact factor: 6.118

4.  A utility valuation study assessing the impact of postprandial glucose control on quality of life of individuals with type 1 or type 2 diabetes.

Authors:  J Jendle; A Sandberg; S Buchs; P Swinburn; M Hadi; L Å Levin
Journal:  J Patient Rep Outcomes       Date:  2018-04-17

5.  Impact of glucagon response on early postprandial glucose excursions irrespective of residual β-cell function in type 1 diabetes: A cross-sectional study using a mixed meal tolerance test.

Authors:  Ayako Ito; Ichiro Horie; Masaki Miwa; Ayaka Sako; Tetsuro Niri; Yomi Nakashima; Riyoko Shigeno; Ai Haraguchi; Shoko Natsuda; Satoru Akazawa; Akie Kamada; Atsushi Kawakami; Norio Abiru
Journal:  J Diabetes Investig       Date:  2021-01-22       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.